Bleximenib in combination with intensive chemotherapy: A phase 1b study in newly diagnosed Acute Myeloid Leukemia with KMT2A or NPM1 alterationsHartmut Döhner, Andrew H. Wei, Alicia J. Allred et al.|Blood|2025Cited by 10
Phase 1b study of bleximenib in combination with venetoclax in Acute Myeloid Leukemia with KMT2A or NPM1 alterationsJenny O’Nions, Sylvain Garciaz, Andrew H. Wei et al.|Blood|2025Cited by 4
Results of the APG2575AU101 Study of lisaftoclax (APG-2575) combined with azacitidine (AZA) in patients with newly diagnosed (ND) or prior venetoclax–exposed myeloid malignanciesTapan M. Kadia, Yifan Zhai, Patricia Kropf et al.|Blood|2025Cited by 2